Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud-based, On-premise), By End-use, By Region, And Segment Forecasts, 2023

The global clinical trials matching software market size is expected to reach USD 396.1 million by 2030, based on a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 13.2% from 2023 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches.

In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 scenario.

The software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in rheumatology.

Clinical Trials Matching Software Market Report Highlights:

Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2022 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred
Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2022 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities
The CROs end-use segment is anticipated to expand at the fastest CAGR of 13.7% during the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective
In 2022, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region
Asia Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates

Product Code: GVR-4-68039-921-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Deployment Mode
- 1.1.2. End-use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Deployment mode outlook
- 2.2.2. End-use outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Clinical Trials Matching Software Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Clinical Trials Matching Software Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic Landscape

Chapter 4. Clinical Trials Matching Software: Deployment Mode Estimates & Trend Analysis

4.1. Clinical Trials Matching Software Market: Key Takeaways
4.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Web & Cloud-based
- 4.3.1. Web & Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. On-premises
- 4.4.1. On-premises market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Matching Software: End-use Estimates & Trend Analysis

5.1. Clinical Trials Matching Software Market: Key Takeaways
5.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Pharmaceutical & Biotechnology Companies
- 5.3.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. CROs
- 5.4.1. CROs market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Medical Device Firms
- 5.5.1. Medical Device Firms market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Matching Software Market: Regional Estimates & Trend Analysis

6.1. Regional Outlook
6.2. Clinical Trials Matching Software Market by Region: Key Marketplace Takeaway
6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
  - 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
  - 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
- 6.4.1. UK
  - 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
  - 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
  - 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
  - 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
  - 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
  - 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
  - 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
  - 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
- 6.5.1. Japan
  - 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
  - 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
  - 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
  - 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
  - 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
  - 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
- 6.6.1. Brazil
  - 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
  - 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
  - 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
- 6.7.1. Saudi Arabia
  - 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
  - 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
  - 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
  - 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
- 7.2.1. IBM Clinical Development
  - 7.2.1.1. Company overview
  - 7.2.1.2. Financial performance
  - 7.2.1.3. Product benchmarking
  - 7.2.1.4. Strategic initiatives
- 7.2.2. Antidote Technologies, INC.
  - 7.2.2.1. Company overview
  - 7.2.2.2. Financial performance
  - 7.2.2.3. Product benchmarking
  - 7.2.2.4. Strategic initiatives
- 7.2.3. Ofni Systems
  - 7.2.3.1. Company overview
  - 7.2.3.2. Financial performance
  - 7.2.3.3. Product benchmarking
  - 7.2.3.4. Strategic initiatives
- 7.2.4. Sss International Clinical Research
  - 7.2.4.1. Company overview
  - 7.2.4.2. Financial performance
  - 7.2.4.3. Product benchmarking
  - 7.2.4.4. Strategic initiatives
- 7.2.5. Clario
  - 7.2.5.1. Company overview
  - 7.2.5.2. Financial performance
  - 7.2.5.3. Product benchmarking
  - 7.2.5.4. Strategic initiatives
- 7.2.6. Advarra
  - 7.2.6.1. Company overview
  - 7.2.6.2. Financial performance
  - 7.2.6.3. Product benchmarking
  - 7.2.6.4. Strategic initiatives
- 7.2.7. Aris Global
  - 7.2.7.1. Company overview
  - 7.2.7.2. Financial performance
  - 7.2.7.3. Product benchmarking
  - 7.2.7.4. Strategic initiatives
- 7.2.8. Bsi Business Systems Integration Ag
  - 7.2.8.1. Company overview
  - 7.2.8.2. Financial performance
  - 7.2.8.3. Product benchmarking
  - 7.2.8.4. Strategic initiatives
- 7.2.9. Teckro
  - 7.2.9.1. Company overview
  - 7.2.9.2. Financial performance
  - 7.2.9.3. Product benchmarking
  - 7.2.9.4. Strategic initiatives
- 7.2.10. Clinical Trials Mobile Application
  - 7.2.10.1. Company overview
  - 7.2.10.2. Financial performance
  - 7.2.10.3. Product benchmarking
  - 7.2.10.4. Strategic initiatives

Product Code: GVR-4-68039-921-8

List of Tables

Table 1 List of Abbreviations
Table 2 North America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 3 North America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 6 U.S. clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 8 Canada clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 10 Europe clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe clinical trials matching software market, by region, 2018 - 2030 (USD Million)
Table 12 Germany clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 13 Germany clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 15 UK clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 16 France clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 17 France clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 19 Italy clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 21 Spain clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 23 Sweden clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 25 Norway clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 27 Denmark clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 29 Asia Pacific clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific clinical trials matching software market, by region, 2018 - 2030 (USD Million)
Table 31 China clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 32 China clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 34 Japan clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 35 India clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 36 India clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
Table 37 Australia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 38 Australia clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
Table 39 Thailand clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 40 Thailand clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 42 South Korea clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 44 Latin America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 47 Brazil clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 49 Mexico clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 51 Argentina clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa clinical trials matching software market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 56 South Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 60 UAE clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
Table 62 Kuwait clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Clinical trials matching software: Market outlook
Fig. 9 Clinical trials matching software: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Clinical trials matching software market driver impact
Fig. 15 Clinical trials matching software market restraint impact
Fig. 16 Clinical trials matching software market strategic initiatives analysis
Fig. 17 Clinical trials matching software market: Deployment mode movement analysis
Fig. 18 Clinical trials matching software market: Deployment mode outlook and key takeaways
Fig. 19 Web & cloud-based market estimates and forecasts, 2018 - 2030
Fig. 20 On-premises market estimates and forecasts, 2018 - 2030
Fig. 21 Clinical trials matching software market: End-use movement analysis
Fig. 22 Clinical trials matching software market: End-use outlook and key takeaways
Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 24 CROs market estimates and forecasts, 2018 - 2030
Fig. 25 Medical devices firms market estimates and forecasts, 2018 - 2030
Fig. 26 Global clinical trials matching software market: Regional movement analysis
Fig. 27 Global clinical trials matching software market: Regional outlook and key takeaways
Fig. 28 North America market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
Fig. 30 Canada market estimates and forecasts, 2018 - 2030
Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
Fig. 32 UK market estimates and forecasts, 2018 - 2030
Fig. 33 Germany market estimates and forecasts, 2018 - 2030
Fig. 34 France market estimates and forecasts, 2018 - 2030
Fig. 35 Italy market estimates and forecasts, 2018 - 2030
Fig. 36 Spain market estimates and forecasts, 2018 - 2030
Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
Fig. 38 Norway market estimates and forecasts, 2018 - 2030
Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 41 Japan market estimates and forecasts, 2018 - 2030
Fig. 42 China market estimates and forecasts, 2018 - 2030
Fig. 43 India market estimates and forecasts, 2018 - 2030
Fig. 44 Australia market estimates and forecasts, 2018 - 2030
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
Fig. 54 UAE market estimates and forecasts, 2018 - 2030
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030

Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud-based, On-premise), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Clinical Trials Matching Software Market Growth & Trends:

Clinical Trials Matching Software Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Clinical Trials Matching Software Market Variables, Trends & Scope

Chapter 4. Clinical Trials Matching Software: Deployment Mode Estimates & Trend Analysis

Chapter 5. Clinical Trials Matching Software: End-use Estimates & Trend Analysis

Chapter 6. Clinical Trials Matching Software Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

List of Tables

List of Figures